Literature DB >> 14605947

Cloning and mutation analysis of ZFP276 as a candidate tumor suppressor in breast cancer.

Jasmine C Y Wong1,2, Nalan Gokgoz3, Noa Alon4, Irene L Andrulis5,3, Manuel Buchwald4,5.   

Abstract

Loss of heterozygosity (LOH) involving chromosome 16q23.4 occurs frequently in breast tumors, which suggests that this region may contain a tumor suppressor gene. Since ZFP276 is located in this region, we have therefore cloned and performed mutation analysis of its coding region in 70 breast tumors. One silent polymorphism and two alterations predicted to result in amino acid changes were detected. Absence of the wild-type allele in tumors carrying the E530D variant suggests a possible role for this change in tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14605947     DOI: 10.1007/s10038-003-0088-1

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  12 in total

1.  Cloning and analysis of the mouse Fanconi anemia group A cDNA and an overlapping penta zinc finger cDNA.

Authors:  J C Wong; N Alon; K Norga; F A Kruyt; H Youssoufian; M Buchwald
Journal:  Genomics       Date:  2000-08-01       Impact factor: 5.736

2.  Cloning of cDNAs for Fanconi's anaemia by functional complementation.

Authors:  C A Strathdee; H Gavish; W R Shannon; M Buchwald
Journal:  Nature       Date:  1992-04-30       Impact factor: 49.962

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

4.  Single-nucleotide polymorphisms can cause different structural folds of mRNA.

Authors:  L X Shen; J P Basilion; V P Stanton
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

5.  Characterization of copine VII, a new member of the copine family, and its exclusion as a candidate in sporadic breast cancers with loss of heterozygosity at 16q24.3.

Authors:  M Savino; M d'Apolito; M Centra; H M van Beerendonk; A M Cleton-Jansen; S A Whitmore; J Crawford; D F Callen; L Zelante; A Savoia
Journal:  Genomics       Date:  1999-10-15       Impact factor: 5.736

6.  Comparison of p53 mutations in patients with localized osteosarcoma and metastatic osteosarcoma.

Authors:  N Gokgoz; J S Wunder; S Mousses; S Eskandarian; R S Bell; I L Andrulis
Journal:  Cancer       Date:  2001-10-15       Impact factor: 6.860

7.  Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions.

Authors:  A M Cleton-Jansen; D F Callen; R Seshadri; S Goldup; B Mccallum; J Crawford; J A Powell; C Settasatian; H van Beerendonk; E W Moerland; V T Smit; W H Harris; R Millis; N V Morgan; D Barnes; C G Mathew; C J Cornelisse
Journal:  Cancer Res       Date:  2001-02-01       Impact factor: 12.701

8.  Functional synergism between the most common polymorphism in human alanine:glyoxylate aminotransferase and four of the most common disease-causing mutations.

Authors:  M J Lumb; C J Danpure
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

9.  Deletion map of chromosome 16q in ductal carcinoma in situ of the breast: refining a putative tumor suppressor gene region.

Authors:  T Chen; A Sahin; C M Aldaz
Journal:  Cancer Res       Date:  1996-12-15       Impact factor: 12.701

10.  Characterization and screening for mutations of the growth arrest-specific 11 (GAS11) and C16orf3 genes at 16q24.3 in breast cancer.

Authors:  S A Whitmore; C Settasatian; J Crawford; K M Lower; B McCallum; R Seshadri; C J Cornelisse; E W Moerland; A M Cleton-Jansen; A J Tipping; C G Mathew; M Savnio; A Savoia; P Verlander; A D Auerbach; C Van Berkel; J C Pronk; N A Doggett; D F Callen
Journal:  Genomics       Date:  1998-09-15       Impact factor: 5.736

View more
  5 in total

1.  Distinct mechanisms of transcriptional pausing orchestrated by GAGA factor and M1BP, a novel transcription factor.

Authors:  Jian Li; David S Gilmour
Journal:  EMBO J       Date:  2013-05-24       Impact factor: 11.598

2.  Use of signals of positive and negative selection to distinguish cancer genes and passenger genes.

Authors:  László Bányai; Maria Trexler; Krisztina Kerekes; Orsolya Csuka; László Patthy
Journal:  Elife       Date:  2021-01-11       Impact factor: 8.140

3.  ZNF276 promotes the malignant phenotype of breast carcinoma by activating the CYP1B1-mediated Wnt/β-catenin pathway.

Authors:  Ting Lei; Wenwu Zhang; Yongyin He; Shi Wei; Xiaoyu Song; Yi Zhu; Guoqing Luo; Zhenzhan Kuang; Guanjie Li; Quan Zhou; Zhaohui Sun; Bin Xiao; Linhai Li
Journal:  Cell Death Dis       Date:  2022-09-10       Impact factor: 9.685

4.  The Drosophila Zinc Finger Transcription Factor Ouija Board Controls Ecdysteroid Biosynthesis through Specific Regulation of spookier.

Authors:  Tatsuya Komura-Kawa; Keiko Hirota; Yuko Shimada-Niwa; Rieko Yamauchi; MaryJane Shimell; Tetsuro Shinoda; Akiyoshi Fukamizu; Michael B O'Connor; Ryusuke Niwa
Journal:  PLoS Genet       Date:  2015-12-10       Impact factor: 5.917

5.  Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer.

Authors:  Siddhartha P Kar; Daniel P C Considine; Jonathan P Tyrer; Jasmine T Plummer; Stephanie Chen; Felipe S Dezem; Alvaro N Barbeira; Padma S Rajagopal; Will T Rosenow; Fernando Moreno; Clara Bodelon; Jenny Chang-Claude; Georgia Chenevix-Trench; Anna deFazio; Thilo Dörk; Arif B Ekici; Ailith Ewing; George Fountzilas; Ellen L Goode; Mikael Hartman; Florian Heitz; Peter Hillemanns; Estrid Høgdall; Claus K Høgdall; Tomasz Huzarski; Allan Jensen; Beth Y Karlan; Elza Khusnutdinova; Lambertus A Kiemeney; Susanne K Kjaer; Rüdiger Klapdor; Martin Köbel; Jingmei Li; Clemens Liebrich; Taymaa May; Håkan Olsson; Jennifer B Permuth; Paolo Peterlongo; Paolo Radice; Susan J Ramus; Marjorie J Riggan; Harvey A Risch; Emmanouil Saloustros; Jacques Simard; Lukasz M Szafron; Linda Titus; Cheryl L Thompson; Robert A Vierkant; Stacey J Winham; Wei Zheng; Jennifer A Doherty; Andrew Berchuck; Kate Lawrenson; Hae Kyung Im; Ani W Manichaikul; Paul D P Pharoah; Simon A Gayther; Joellen M Schildkraut
Journal:  HGG Adv       Date:  2021-06-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.